Main > RHEUMATOLOGY > KR. C. RA>Treat.>TNF-Alpha MAb SC>

---

KR. C. RA>Treat.>TNF-Alpha MAb SC>'s subsections
(*) Approved in CA; EU & KR
>Formulation
Generic Name: InflixiMAb
MAb: Monoclonal Antibody
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 06.08.
RTM
RTM Web-Site
SC: SubCutaneous
TNF: Tumor Necrosis Factor

KR. C. RA>Treat.>TNF-Alpha MAb SC>'s products
This section has no products